InsiderClue
Insiders · Profile

PERCEPTIVE ADVISORS LLC

Director at Immatics N.V · 10% owner at Orchestra BioMed · 10% owner at Acrivon Therapeutics · and 12 more. Filing since 23 Jul 2013. CIK 0001224962

IMTX Immatics N.V. Director · 1 trade OBIO Orchestra BioMed Holdings, Inc. 10% owner · 1 trade ACRV Acrivon Therapeutics, Inc. 10% owner · 6 trades ALDX Aldeyra Therapeutics, Inc. 10% owner · 31 trades SLDB Solid Biosciences Inc. Director · 5 trades MGTX MeiraGTx Holdings plc Director · 6 trades VRCA Verrica Pharmaceuticals Inc. 10% owner · 11 trades LONA LeonaBio, Inc. Director · 7 trades CRNX Crinetics Pharmaceuticals, Inc. 10% owner · 5 trades NAUT Nautilus Biotechnology, Inc. Director · 5 trades ADMA ADMA BIOLOGICS, INC. 10% owner · 12 trades YARW Yarrow Bioscience, Inc. 10% owner · 6 trades SCYX SCYNEXIS INC 10% owner · 3 trades CYPH CYPHERPUNK TECHNOLOGIES INC. 10% owner · 1 trade TLPH TALPHERA, INC. 10% owner · 15 trades
Company
Date
Role
Action
Shares
Amount
Of holding
IMTX Immatics N.V.
26 Aug 2026
Director
Bought
863,060
$7.50M
8.3%
OBIO Orchestra BioMed Holdings, Inc.
1 Aug 2025
10% owner
Bought
700,000
$1.93M
15.2%
ACRV Acrivon Therapeutics, Inc.
1 May 2025
10% owner
Sold at will
298,886
$400.51K
8.8%
ACRV Acrivon Therapeutics, Inc.
30 Apr 2025
10% owner
Sold at will
437,881
$617.41K
11.4%
ACRV Acrivon Therapeutics, Inc.
29 Apr 2025
10% owner
Sold at will
250,000
$352.50K
6.1%
ACRV Acrivon Therapeutics, Inc.
28 Apr 2025
10% owner
Sold at will
215,283
$335.84K
5.0%
ACRV Acrivon Therapeutics, Inc.
25 Apr 2025
10% owner
Sold at will
1,054,669
$2.06M
19.7%
ALDX Aldeyra Therapeutics, Inc.
3 Apr 2025
10% owner
Sold at will
3,400,000
$4.83M
36.7%
SLDB Solid Biosciences Inc.
19 Feb 2025
Director
Bought
5,000,000
$20.15M
73.2%
MGTX MeiraGTx Holdings plc
12 Aug 2024
Director
Bought
1,250,000
$5.00M
11.1%
ACRV Acrivon Therapeutics, Inc.
11 Apr 2024
10% owner
Bought
2,353,000
$20.00M
78.2%
ALDX Aldeyra Therapeutics, Inc.
5 Apr 2024
10% owner
Bought
37,712
$178.75K
0.4%
ALDX Aldeyra Therapeutics, Inc.
4 Apr 2024
10% owner
Bought
140,281
$655.11K
1.5%
ALDX Aldeyra Therapeutics, Inc.
3 Apr 2024
10% owner
Bought
309,847
$1.27M
3.5%
ALDX Aldeyra Therapeutics, Inc.
2 Apr 2024
10% owner
Bought
186,051
$640.02K
2.2%
ALDX Aldeyra Therapeutics, Inc.
1 Apr 2024
10% owner
Bought
8,374
$27.22K
0.1%
SLDB Solid Biosciences Inc.
11 Jan 2024
Director
Bought
3,410,713
$18.86M
99.6%
VRCA Verrica Pharmaceuticals Inc.
29 Dec 2023
10% owner
Bought
115,774
$838.20K
1.7%
LONA LeonaBio, Inc.
29 Dec 2023
Director
Bought
163,954
$390.21K
3.1%
LONA LeonaBio, Inc.
28 Dec 2023
Director
Bought
409,598
$999.42K
8.5%
VRCA Verrica Pharmaceuticals Inc.
28 Dec 2023
10% owner
Bought
126,116
$892.90K
1.8%
VRCA Verrica Pharmaceuticals Inc.
27 Dec 2023
10% owner
Bought
79,726
$574.03K
1.2%
LONA LeonaBio, Inc.
27 Dec 2023
Director
Bought
32,134
$73.27K
0.7%
VRCA Verrica Pharmaceuticals Inc.
26 Dec 2023
10% owner
Bought
54,652
$354.69K
0.8%
VRCA Verrica Pharmaceuticals Inc.
22 Dec 2023
10% owner
Bought
250,000
$1.67M
3.9%
VRCA Verrica Pharmaceuticals Inc.
21 Dec 2023
10% owner
Bought
200,000
$1.23M
3.2%
VRCA Verrica Pharmaceuticals Inc.
19 Dec 2023
10% owner
Bought
277,008
$1.48M
4.6%
VRCA Verrica Pharmaceuticals Inc.
18 Dec 2023
10% owner
Bought
456,923
$2.47M
8.2%
VRCA Verrica Pharmaceuticals Inc.
15 Dec 2023
10% owner
Bought
500,000
$2.99M
9.9%
ALDX Aldeyra Therapeutics, Inc.
18 Oct 2023
10% owner
Sold at will
306,499
$533.31K
3.4%
ALDX Aldeyra Therapeutics, Inc.
16 Oct 2023
10% owner
Sold at will
2,450,000
$3.92M
21.6%
MGTX MeiraGTx Holdings plc
5 May 2023
Director
Bought
4,347,826
$25.00M
62.7%
ALDX Aldeyra Therapeutics, Inc.
10 Aug 2022
10% owner
Bought
15,000
$117.75K
0.1%
ALDX Aldeyra Therapeutics, Inc.
9 Aug 2022
10% owner
Bought
100,000
$750.00K
0.9%
ALDX Aldeyra Therapeutics, Inc.
8 Aug 2022
10% owner
Bought
97,000
$702.28K
0.9%
ALDX Aldeyra Therapeutics, Inc.
5 Aug 2022
10% owner
Bought
141,000
$979.95K
1.3%
ALDX Aldeyra Therapeutics, Inc.
4 Aug 2022
10% owner
Bought
95,100
$586.77K
0.9%
ALDX Aldeyra Therapeutics, Inc.
3 Aug 2022
10% owner
Bought
100,000
$584.00K
0.9%
ALDX Aldeyra Therapeutics, Inc.
2 Aug 2022
10% owner
Bought
412,406
$2.31M
4.0%
ALDX Aldeyra Therapeutics, Inc.
1 Aug 2022
10% owner
Bought
144,185
$728.13K
1.4%
ALDX Aldeyra Therapeutics, Inc.
29 Jul 2022
10% owner
Bought
222,123
$1.12M
2.2%
ALDX Aldeyra Therapeutics, Inc.
28 Jul 2022
10% owner
Bought
119,392
$596.96K
1.2%
VRCA Verrica Pharmaceuticals Inc.
5 Jul 2022
10% owner
Bought
1,428,571
$3.00M
39.6%
LONA LeonaBio, Inc.
30 Jun 2022
Director
Bought
1,101,362
$3.29M
29.8%
LONA LeonaBio, Inc.
29 Jun 2022
Director
Bought
270,000
$807.30K
7.9%
CRNX Crinetics Pharmaceuticals, Inc.
18 Apr 2022
10% owner
Bought
157,515
$3.50M
3.1%
NAUT Nautilus Biotechnology, Inc.
8 Dec 2021
Director
Bought
200,000
$1.07M
2.2%
CRNX Crinetics Pharmaceuticals, Inc.
25 Oct 2021
10% owner
Bought
1,200,000
$23.76M
30.3%
ADMA ADMA BIOLOGICS, INC.
30 Sep 2021
10% owner
Sold, plan not stated
137,495
$153.99K
1.0%
ADMA ADMA BIOLOGICS, INC.
29 Sep 2021
10% owner
Sold, plan not stated
82,505
$95.71K
0.6%
ADMA ADMA BIOLOGICS, INC.
28 Sep 2021
10% owner
Sold, plan not stated
40,603
$49.54K
0.3%
ADMA ADMA BIOLOGICS, INC.
27 Sep 2021
10% owner
Sold, plan not stated
250,000
$307.50K
1.8%
ADMA ADMA BIOLOGICS, INC.
24 Sep 2021
10% owner
Sold, plan not stated
250,000
$315.00K
1.8%
ADMA ADMA BIOLOGICS, INC.
23 Sep 2021
10% owner
Sold, plan not stated
780,000
$990.60K
5.3%
ADMA ADMA BIOLOGICS, INC.
19 Aug 2021
10% owner
Sold, plan not stated
350,352
$434.44K
2.3%
ADMA ADMA BIOLOGICS, INC.
18 Aug 2021
10% owner
Sold, plan not stated
552,380
$712.57K
3.5%
ADMA ADMA BIOLOGICS, INC.
17 Aug 2021
10% owner
Sold, plan not stated
879,092
$1.19M
5.3%
YARW Yarrow Bioscience, Inc.
16 Aug 2021
10% owner
Sold, plan not stated
250,000
$435.00K
4.8%
YARW Yarrow Bioscience, Inc.
13 Aug 2021
10% owner
Sold, plan not stated
250,000
$460.00K
4.6%
YARW Yarrow Bioscience, Inc.
12 Aug 2021
10% owner
Sold, plan not stated
338,897
$755.74K
5.9%
NAUT Nautilus Biotechnology, Inc.
9 Jun 2021
Former Director
Bought
5,500,000
$55.00M
×11
NAUT Nautilus Biotechnology, Inc.
3 Jun 2021
Director
Bought
330,050
$3.32M
206%
NAUT Nautilus Biotechnology, Inc.
24 May 2021
Former Director
Bought
7,063
$70.98K
1.4%
NAUT Nautilus Biotechnology, Inc.
20 May 2021
Director
Bought
159,925
$1.61M
opened
YARW Yarrow Bioscience, Inc.
6 May 2021
10% owner
Sold, plan not stated
1,000,000
$3.67M
14.8%
ALDX Aldeyra Therapeutics, Inc.
3 May 2021
10% owner
Bought
1,200,000
$15.00M
13.8%
CRNX Crinetics Pharmaceuticals, Inc.
8 Apr 2021
10% owner
Bought
304,136
$5.00M
8.3%
SLDB Solid Biosciences Inc.
23 Mar 2021
Director
Bought
2,608,695
$15.00M
24.1%
YARW Yarrow Bioscience, Inc.
28 Jan 2021
10% owner
Bought
4,219,409
$10.00M
18.4%
LONA LeonaBio, Inc.
25 Jan 2021
Director
Bought
311,111
$7.00M
10.0%
SCYX SCYNEXIS INC
22 Jan 2021
10% owner
Sold, plan not stated
319,000
$2.63M
15.1%
SCYX SCYNEXIS INC
21 Jan 2021
10% owner
Sold, plan not stated
95,000
$701.10K
4.3%
SCYX SCYNEXIS INC
20 Jan 2021
10% owner
Sold, plan not stated
185,000
$1.37M
7.7%
ALDX Aldeyra Therapeutics, Inc.
19 Jan 2021
10% owner
Bought
1,368,421
$13.00M
18.7%
ALDX Aldeyra Therapeutics, Inc.
8 Jan 2021
10% owner
Bought
550,000
$5.14M
8.1%
ALDX Aldeyra Therapeutics, Inc.
7 Jan 2021
10% owner
Bought
500,000
$4.07M
8.0%
MGTX MeiraGTx Holdings plc
23 Nov 2020
Director
Bought
500,000
$6.43M
7.8%
LONA LeonaBio, Inc.
22 Sep 2020
10% owner
Bought
1,058,824
$18.00M
51.5%
ALDX Aldeyra Therapeutics, Inc.
9 Jul 2020
10% owner
Bought
3,200,000
$13.60M
104%
CYPH CYPHERPUNK TECHNOLOGIES INC.
22 Jun 2020
10% owner
Bought
1,750,000
$3.50M
26.0%
YARW Yarrow Bioscience, Inc.
9 Jun 2020
10% owner
Bought
2,702,702
$5.00M
13.4%
CRNX Crinetics Pharmaceuticals, Inc.
17 Apr 2020
10% owner
Bought
1,071,428
$15.00M
41.4%
ADMA ADMA BIOLOGICS, INC.
19 Mar 2020
10% owner
Bought
500,000
$1.05M
3.1%
ADMA ADMA BIOLOGICS, INC.
11 Feb 2020
10% owner
Bought
4,563,700
$15.97M
39.6%
MGTX MeiraGTx Holdings plc
12 Aug 2019
Director
Bought
425,531
$10.00M
7.1%
SLDB Solid Biosciences Inc.
25 Jul 2019
Director
Bought
2,822,581
$13.13M
71.9%
ADMA ADMA BIOLOGICS, INC.
21 May 2019
10% owner
Bought
4,000,000
$16.00M
53.2%
CRNX Crinetics Pharmaceuticals, Inc.
20 Jul 2018
Director
Bought
400,000
$6.80M
21.3%
VRCA Verrica Pharmaceuticals Inc.
19 Jun 2018
10% owner
Bought
1,000,000
$15.00M
41.5%
MGTX MeiraGTx Holdings plc
12 Jun 2018
Director
Bought
1,333,333
$20.00M
39.6%
MGTX MeiraGTx Holdings plc
8 Jun 2018
Director
Bought
50,000
$761.00K
1.5%
SLDB Solid Biosciences Inc.
30 Jan 2018
Director
Bought
1,020,000
$16.55M
35.1%
ALDX Aldeyra Therapeutics, Inc.
19 Sep 2017
10% owner
Bought
200,000
$1.45M
6.9%
ALDX Aldeyra Therapeutics, Inc.
30 Jun 2017
10% owner
Bought
296,007
$1.36M
11.4%
TLPH TALPHERA, INC.
19 Jun 2017
10% owner
Sold, plan not stated
875,000
$2.10M
16.2%
ALDX Aldeyra Therapeutics, Inc.
14 Feb 2017
10% owner
Bought
893,025
$4.02M
52.6%
TLPH TALPHERA, INC.
29 Sep 2016
10% owner
Sold, plan not stated
97,200
$377.12K
1.8%
TLPH TALPHERA, INC.
28 Sep 2016
10% owner
Sold, plan not stated
119,300
$472.38K
2.1%
TLPH TALPHERA, INC.
15 Sep 2016
10% owner
Sold, plan not stated
392,850
$1.45M
6.6%
ALDX Aldeyra Therapeutics, Inc.
26 May 2016
10% owner
Bought
700,000
$3.50M
56.4%
TLPH TALPHERA, INC.
18 Nov 2015
10% owner
Sold, plan not stated
42,300
$226.13K
0.7%
TLPH TALPHERA, INC.
17 Nov 2015
10% owner
Sold, plan not stated
133,900
$717.41K
2.2%
TLPH TALPHERA, INC.
6 Nov 2015
10% owner
Sold, plan not stated
17,100
$76.37K
0.3%
TLPH TALPHERA, INC.
5 Nov 2015
10% owner
Sold, plan not stated
75,000
$346.26K
1.2%
ALDX Aldeyra Therapeutics, Inc.
28 Oct 2015
10% owner
Bought
45,100
$293.15K
3.8%
ALDX Aldeyra Therapeutics, Inc.
26 Oct 2015
10% owner
Bought
50,000
$323.15K
4.4%
ALDX Aldeyra Therapeutics, Inc.
22 Oct 2015
10% owner
Bought
18,020
$116.66K
1.6%
ALDX Aldeyra Therapeutics, Inc.
20 Oct 2015
10% owner
Bought
37,145
$237.19K
3.4%
TLPH TALPHERA, INC.
9 Sep 2015
10% owner
Sold, plan not stated
310,000
$1.29M
4.7%
TLPH TALPHERA, INC.
7 Nov 2013
10% owner
Bought
100,000
$649.81K
1.5%
TLPH TALPHERA, INC.
6 Nov 2013
10% owner
Bought
100,000
$651.66K
1.6%
TLPH TALPHERA, INC.
4 Nov 2013
10% owner
Bought
155,000
$1.06M
2.5%
TLPH TALPHERA, INC.
1 Nov 2013
10% owner
Bought
160,660
$1.15M
2.7%
TLPH TALPHERA, INC.
31 Oct 2013
10% owner
Bought
200,000
$1.34M
3.4%
TLPH TALPHERA, INC.
23 Jul 2013
10% owner
Bought
850,000
$9.90M
17.0%
115 decisions on file.